Live News EQUITY FLASH L impact Oct 26, 2026, 11:27 AM UTC Contineum Therapeutics Expected to Post 45-Cent Per-Share Loss An earnings preview expects Contineum Therapeutics to report a loss of 45 cents per share. CTNM SquawkNews Desk